Higher Neural Correlates in Multiple Sclerosis Patients with Neurogenic Overactive Bladder Following Treatment with Intradetrusor Injection of OnabotulinumtoxinA
OnabotulinumtoxinA (OnabotA) is a well-described treatment for Neurogenic Overactive Bladder (NOAB) and while its motor effects on detrusor muscle is extensively studied, its sensory effects are not. The aim of this study was to evaluate the impact of intradetrusor OnabotA injection on brain activity in female multiple sclerosis (MS) patients with NOAB.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Rose Khavari, Saba N. Elias, Rashmi Pande, Katherine M. Wu, Timothy B. Boone, Christof Karmonik Source Type: research
More News: Brain | Multiple Sclerosis | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology